These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28807994)

  • 1. A Novel Computational Model Predicts Key Regulators of Chemokine Gradient Formation in Lymph Nodes and Site-Specific Roles for CCL19 and ACKR4.
    Jafarnejad M; Zawieja DC; Brook BS; Nibbs RJB; Moore JE
    J Immunol; 2017 Oct; 199(7):2291-2304. PubMed ID: 28807994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACKR4 on Stromal Cells Scavenges CCL19 To Enable CCR7-Dependent Trafficking of APCs from Inflamed Skin to Lymph Nodes.
    Bryce SA; Wilson RA; Tiplady EM; Asquith DL; Bromley SK; Luster AD; Graham GJ; Nibbs RJ
    J Immunol; 2016 Apr; 196(8):3341-53. PubMed ID: 26976955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
    Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins.
    Matti C; Salnikov A; Artinger M; D'Agostino G; Kindinger I; Uguccioni M; Thelen M; Legler DF
    Front Immunol; 2020; 11():720. PubMed ID: 32391018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL20 is a novel ligand for the scavenging atypical chemokine receptor 4.
    Matti C; D'Uonnolo G; Artinger M; Melgrati S; Salnikov A; Thelen S; Purvanov V; Strobel TD; Spannagel L; Thelen M; Legler DF
    J Leukoc Biol; 2020 Jun; 107(6):1137-1154. PubMed ID: 32533638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scavenging of soluble and immobilized CCL21 by ACKR4 regulates peripheral dendritic cell emigration.
    Bastow CR; Bunting MD; Kara EE; McKenzie DR; Caon A; Devi S; Tolley L; Mueller SN; Frazer IH; Harvey N; Condina MR; Young C; Hoffmann P; McColl SR; Comerford I
    Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33875601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.
    Haessler U; Pisano M; Wu M; Swartz MA
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5614-9. PubMed ID: 21422278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the Atypical Chemokine Receptor ACKR4 Identifies a Novel Population of Intestinal Submucosal Fibroblasts That Preferentially Expresses Endothelial Cell Regulators.
    Thomson CA; van de Pavert SA; Stakenborg M; Labeeuw E; Matteoli G; Mowat AM; Nibbs RJB
    J Immunol; 2018 Jul; 201(1):215-229. PubMed ID: 29760193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanosensitive ACKR4 scavenges CCR7 chemokines to facilitate T cell de-adhesion and passive transport by flow in inflamed afferent lymphatics.
    Friess MC; Kritikos I; Schineis P; Medina-Sanchez JD; Gkountidi AO; Vallone A; Sigmund EC; Schwitter C; Vranova M; Matti C; Arasa J; Saygili Demir C; Bovay E; Proulx ST; Tomura M; Rot A; Legler DF; Petrova TV; Halin C
    Cell Rep; 2022 Feb; 38(5):110334. PubMed ID: 35108538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes.
    Ulvmar MH; Werth K; Braun A; Kelay P; Hub E; Eller K; Chan L; Lucas B; Novitzky-Basso I; Nakamura K; Rülicke T; Nibbs RJ; Worbs T; Förster R; Rot A
    Nat Immunol; 2014 Jul; 15(7):623-30. PubMed ID: 24813163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.
    Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K
    J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19.
    Britschgi MR; Favre S; Luther SA
    Eur J Immunol; 2010 May; 40(5):1266-71. PubMed ID: 20201039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.
    Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM
    Front Immunol; 2019; 10():2156. PubMed ID: 31572374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between ACKR4 and CCR7 genes expression and breast cancer metastasis.
    Mohammed MM; Shaker O; Ramzy MM; Gaber SS; Kamel HS; Abed El Baky MF
    Life Sci; 2021 Aug; 279():119691. PubMed ID: 34102193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR7 signaling inhibits T cell proliferation.
    Ziegler E; Oberbarnscheidt M; Bulfone-Paus S; Förster R; Kunzendorf U; Krautwald S
    J Immunol; 2007 Nov; 179(10):6485-93. PubMed ID: 17982037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis.
    Oliveira-Neto HH; de Souza PP; da Silva MR; Mendonça EF; Silva TA; Batista AC
    Tumour Biol; 2013 Feb; 34(1):65-70. PubMed ID: 22976543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Fates of Chemokine and Surrogate Molecule Gradients: Consequences for CCR7-Guided Dendritic Cell Migration.
    Artinger M; Gerken OJ; Purvanov V; Legler DF
    Front Immunol; 2022; 13():913366. PubMed ID: 35769489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin Specifically Interacts with Basic BBXB Motifs of the Chemokine CCL21 to Define CCR7 Signaling.
    Artinger M; Gerken OJ; Legler DF
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.
    Hauser MA; Legler DF
    J Leukoc Biol; 2016 Jun; 99(6):869-82. PubMed ID: 26729814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active Shaping of Chemokine Gradients by Atypical Chemokine Receptors: A 4D Live-Cell Imaging Migration Assay.
    Werth K; Förster R
    Methods Enzymol; 2016; 570():293-308. PubMed ID: 26921952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.